Amneal Pharmaceuticals, Inc. (AMRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -28.73M | 130.31M | 118.45M | 83.82M | 7.41M | 118.08M | 141.77M | 39.66M | -4.41M | 135.82M | 81.39M | -11.35M |
| Operating CF Margin % | -3.98% | 16% | 15.1% | 11.57% | 1.07% | 16.16% | 20.18% | 5.65% | -0.67% | 22.01% | 13.13% | -1.89% |
| Operating CF Growth % | -487.76% | 10.36% | -16.45% | 111.36% | 267.98% | -13.06% | 74.2% | 449.55% | -103.16% | 683.13% | -13.02% | 90.96% |
| Net Income | 78M | 49.57M | 18.13M | 35.61M | 24.62M | -20.74M | 11.76M | 5.99M | -81.68M | -93.34M | 25.03M | 29.68M |
| Depreciation & Amortization | 0 | 49.23M | 54.07M | 60.11M | 60.16M | 66.13M | 58.96M | 63.02M | 55.53M | 56.93M | 57.21M | 57.11M |
| Stock-Based Compensation | 0 | 8.2M | 8.22M | 8.27M | 7.26M | 7.21M | 7.11M | 6.72M | 6.72M | 5.97M | 6.69M | 6.56M |
| Deferred Taxes | 0 | 0 | -23.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 83.36M | 35.6M | 112.12M | 14.93M | 21.75M | 43.63M | 21.18M | 80.49M | 26.99M | 112.56M | 27.2M | 15.73M |
| Working Capital Changes | -190.08M | -12.29M | -50.74M | -35.11M | -106.38M | 21.86M | 42.77M | -116.57M | -11.97M | 53.7M | -34.74M | -120.43M |
| Change in Receivables | 43.96M | -9.52M | -77.33M | -54.87M | 21.15M | -27.64M | 21.96M | -100.67M | -55.73M | 77.88M | -19.4M | -129.11M |
| Change in Inventory | -54.96M | -20.18M | -30.81M | -22.78M | -13.26M | -51.98M | -43.1M | -23.25M | -12.2M | -23.09M | -42.57M | -38.02M |
| Change in Payables | -124.58M | 18.58M | 69.75M | 45.62M | -112.63M | 66.26M | 46.85M | 0 | 62.17M | -19.76M | 33.08M | 42.72M |
| Cash from Investing | -21.71M | -45.45M | -22.46M | -26.55M | -17.8M | -16.06M | -20.71M | -6.46M | -19.76M | -31.69M | -13.48M | -12.28M |
| Capital Expenditures | -21.71M | -46.17M | -22.46M | -27.4M | -13.16M | -22.46M | -17.11M | -10.7M | -10.06M | -11.79M | -12.48M | -11.13M |
| CapEx % of Revenue | 3% | 5.67% | 2.86% | 3.78% | 1.89% | 3.08% | 2.44% | 1.53% | 1.53% | 1.91% | 2.01% | 1.86% |
| Acquisitions | 0 | 715K | 0 | 855K | 0 | 7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -4.64M | -600K | -3.6M | 4.24M | -9.7M | -19.9M | -1M | -1.15M |
| Cash from Financing | -57.07M | -10.12M | 59.44M | -41.69M | -39.17M | -61.2M | -92.35M | -35.09M | -23.16M | -100.83M | -86.58M | -12.26M |
| Debt Issued (Net) | -6.17M | -6.12M | 67.21M | -17.29M | -17.53M | -55.53M | -87.21M | -27M | -15.38M | 64.16M | -53.94M | 5.09M |
| Equity Issued (Net) | 38K | 553K | 653K | 685K | 69K | 0 | -194K | -159K | 28K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -194K | -159K | 0 | 0 | 0 | 0 |
| Other Financing | -50.94M | -4.55M | -8.42M | -25.08M | -21.71M | -5.67M | -4.94M | -7.93M | -7.81M | -164.99M | -32.64M | -17.35M |
| Net Change in Cash | -109.04M | 74.89M | 154.79M | 15.42M | -50.03M | 40.08M | 28.72M | -2M | -47.49M | 3.5M | -18.98M | -36.49M |
| Free Cash Flow | -42.59M | 87.15M | 103.4M | 57.32M | -10.91M | 95.01M | 121.06M | 28.95M | -24.17M | 104.13M | 67.91M | -23.63M |
| FCF Margin % | -5.89% | 10.7% | 13.18% | 7.91% | -1.57% | 13.01% | 17.23% | 4.13% | -3.67% | 16.88% | 10.95% | -3.94% |
| FCF Growth % | -290.19% | -8.28% | -14.59% | 97.97% | 54.84% | -8.76% | 78.27% | 222.53% | -118.89% | 399.59% | -10.69% | 83.43% |
| FCF per Share | -0.13 | 0.27 | 0.32 | 0.18 | -0.03 | 0.31 | 0.39 | 0.09 | -0.08 | 0.43 | 0.43 | -0.15 |
| FCF Conversion (FCF/Net Income) | -0.46x | 3.72x | 50.00x | 3.74x | 0.61x | -3.80x | -908.81x | 6.62x | 0.05x | -1.38x | 8.41x | -0.95x |
| Interest Paid | 0 | 0 | 0 | 56.32M | 56.32M | 60.6M | 66.37M | 72.03M | 64.51M | 56.21M | 47.9M | 47.64M |
| Taxes Paid | 0 | 0 | 0 | 8.95M | 3.61M | 6.16M | -1.15M | 0 | 4.57M | 2.07M | -3.49M | 0 |